Literature DB >> 3511862

Corticosteroids in rheumatoid arthritis: is a trial of their 'disease modifying' potential feasible?

M A Byron, J R Kirwan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3511862      PMCID： PMC1001842          DOI： 10.1136/ard.45.2.171

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Clinical judgment in rheumatoid arthritis. II. Judging 'current disease activity' in clinical practice.

Authors:  J R Kirwan; D M Chaput de Saintonge; C R Joyce; H L Currey
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

2.  Rheumatoid arthritis: disease-modifying antirheumatic drugs.

Authors:  J R Kirwan; H L Currey
Journal:  Clin Rheum Dis       Date:  1983-12

3.  Long-term study of management of rheumatoid arthritis.

Authors:  R Million; J H Kellgren; P Poole; M I Jayson
Journal:  Lancet       Date:  1984-04-14       Impact factor: 79.321

Review 4.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations.

Authors:  A S Fauci; D C Dale; J E Balow
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

5.  Cross-sectional study of rheumatoid arthritis treatment in a university hospital.

Authors:  W T Friesen; Y A Hekster; L B van de Putte; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

6.  Corticosteroid prescribing in rheumatoid arthritis--the fiction and the fact.

Authors:  M A Byron; A G Mowat
Journal:  Br J Rheumatol       Date:  1985-05

7.  Low dose prednisone therapy in rheumatoid arthritis: a double blind study.

Authors:  E D Harris; R D Emkey; J E Nichols; A Newberg
Journal:  J Rheumatol       Date:  1983-10       Impact factor: 4.666
  7 in total
  11 in total

Review 1.  Rheumatology: 8. Advanced therapy.

Authors:  D Lacaille
Journal:  CMAJ       Date:  2000-09-19       Impact factor: 8.262

Review 2.  Low dose corticosteroids in early rheumatoid arthritis. Can these drugs slow disease progression?

Authors:  J R Kirwan; K K Lim
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

3.  Corticosteroids in rheumatoid arthritis.

Authors:  D M Reid
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

4.  Corticosteroids in rheumatoid arthritis.

Authors:  D J Nashel
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

5.  Treatment of osteoporosis of rheumatoid arthritis.

Authors:  F P Cantatore; M Carrozzo
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 6.  The optimum management of arthropathies.

Authors:  C S Wolfe; G R Hughes
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

Review 7.  Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.

Authors:  M Arnold; L Schrieber; P Brooks
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

8.  Corticosteroid prescribing in rheumatoid arthritis and psoriatic arthritis.

Authors:  W Grassi; R De Angelis; C Cervini
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

9.  Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study.

Authors:  P N Sambrook; M L Cohen; J A Eisman; N A Pocock; G D Champion; M G Yeates
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

Review 10.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.